[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-GLUE":3,"homepage-market-summary":30,"stock-news-GLUE":172},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"GLUE","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Monte Rosa Therapeutics, Inc. Common Stock","Nasdaq",null,"BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)","Monte Rosa Therapeutics Inc is a clinical-stage biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. The company has three programs in clinical development: MRT-6160, a VAV1-directed MGD for immune-mediated diseases; MRT-8102, a NEK7-directed MGD for inflammatory diseases driven by IL-6, and the NLRP3 inflammasome; and MRT-2359, a GSPT1-directed MGD for metastatic castration resistant prostate cancer (mCRPC).","173","Boston, MA",false,{"close":16,"open":17,"high":17,"low":18,"prev_close":19,"change":20,"percent_change":21,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":26,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},10.5,11.4,10.32,11.26,-0.76,-6.75,2213382.642613,21840,10.6421,25.77,7.235,1295990.431875308,17.6,1325,{"status":31,"indices":32,"watchlist":76,"sectors":98,"benchmarks":154},"success",[33,41,48,55,62,69],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":39,"sparkline":40,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":39,"sparkline":47,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":39,"sparkline":54,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":60,"is_up":39,"sparkline":61,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":63,"name":64,"price":65,"change":66,"pct_change":67,"is_up":39,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":14,"sparkline":75,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":39,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":39,"sparkline":90,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":39,"sparkline":97,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[99,104,109,114,119,124,129,134,139,144,149],{"name":100,"etf":101,"change":102,"price":103,"is_up":39},"Technology","XLK",1.01,199.81,{"name":105,"etf":106,"change":107,"price":108,"is_up":39},"Financials","XLF",0.06,53.49,{"name":110,"etf":111,"change":112,"price":113,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":115,"etf":116,"change":117,"price":118,"is_up":39},"Consumer Cycl","XLY",1.13,110.04,{"name":120,"etf":121,"change":122,"price":123,"is_up":39},"Consumer Staples","XLP",0.25,80.53,{"name":125,"etf":126,"change":127,"price":128,"is_up":39},"Energy","XLE",0.4,62.95,{"name":130,"etf":131,"change":132,"price":133,"is_up":39},"Industrials","XLI",0.78,169.95,{"name":135,"etf":136,"change":137,"price":138,"is_up":39},"Materials","XLB",0.66,48.86,{"name":140,"etf":141,"change":142,"price":143,"is_up":39},"Real Estate","XLRE",0.32,40.81,{"name":145,"etf":146,"change":147,"price":148,"is_up":39},"Utilities","XLU",0.38,39.83,{"name":150,"etf":151,"change":152,"price":153,"is_up":39},"Comm Services","XLC",0.35,110.32,[155,160,164,168],{"ticker":156,"name":157,"price":158,"change":159,"is_up":39},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":161,"name":162,"price":163,"change":89,"is_up":39},"QQQ","Invesco QQQ Trust",749.58,{"ticker":165,"name":166,"price":167,"change":53,"is_up":39},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":169,"name":170,"price":171,"change":67,"is_up":39},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":173,"articles":174},20,[175,181,187,193,199,205,211,217,223,229,235,240,245,250,255,260,265,270,275,280],{"title":176,"link":177,"pubDate":178,"description":179,"source":180},"Monte Rosa Therapeutics, Inc. (GLUE) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiUkFVX3lxTE9qRUdNb09sNDJqTzd0NTNTcWhvLUFYSmZ0bnl2aXhhRHdCTEhjbU9jaGkzRkYxNHZXNU8wNlh2RGdhWTJadXBHLWtQZlVEZTlWcFE?oc=5","Sat, 03 Oct 2026 12:02:59 GMT","Monte Rosa Therapeutics, Inc. (GLUE) Stock Price, News, Quote & History Yahoo! Finance Canada","Yahoo! Finance Canada",{"title":182,"link":183,"pubDate":184,"description":185,"source":186},"$GLUE stock is down 8% today. Here's what we see in our data. - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiogFBVV95cUxPbXlUZ2dMTnFvYzl2TkxTZEZFMlpST3NaWlZWRUhVZDlnN2R4aTJyb2RzMXVxWTQyUTRaNmcyMVRqcUNBMkVUdWZUc0hlZWJ6ZVBKVnZ3RlhndjhYNGg5ckNsWUxxbnp6b3pWNDVOZk16MzRTNVo4WGxhbHV3YUJYYkxoTWVQdGIyMHZYdmp4M1poZTRtNVdnTjR0QWlvSktXTlE?oc=5","Fri, 02 Oct 2026 19:18:00 GMT","$GLUE stock is down 8% today. Here's what we see in our data. Quiver Quantitative","Quiver Quantitative",{"title":188,"link":189,"pubDate":190,"description":191,"source":192},"BIOA, GLUE Stocks Clock Worst Day In Years— What’s The NVO Connection? - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiywFBVV95cUxQcllscXNiRzFDbldMMW5uVU5xRGZVUzlRNHQzSzFkWmVPcmRGS1FTRXBqa1NGVDVHVDgzeUNvMF82cnpxMV9WbkI1MWtGVlVVeUtGUnIxa0x1WmhJWWFlUGdheldFWlQzdjA5RXZuM2JjcF9BTUgyTHJTTTI5VEE1TDRhZzVsVWRUSGhLSlo1RGdVVHR5NWN1aGg2aGRNU3JpajBTYjd0WHpWNlRyaUo0NXRGMzRiWExsYmZGTzdHYWVOeklZNldLdVJQRQ?oc=5","Sun, 04 Oct 2026 19:18:59 GMT","BIOA, GLUE Stocks Clock Worst Day In Years— What’s The NVO Connection? Stocktwits","Stocktwits",{"title":194,"link":195,"pubDate":196,"description":197,"source":198},"Monte Rosa Therapeutics, Inc. (GLUE) stock price, news, quote and history - Yahoo Finance UK","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiUkFVX3lxTE1EQnhPYWJwS2lWNTZwcWRabEZFNG9aWUxmYTlnM21xcnJsVU5nZ2NMYWpEQ0E0dFJFN3Rob2dfTFJkam1WcV9xU0Z2RlN0UFlpbUE?oc=5","Sat, 03 Oct 2026 05:41:58 GMT","Monte Rosa Therapeutics, Inc. (GLUE) stock price, news, quote and history Yahoo Finance UK","Yahoo Finance UK",{"title":200,"link":201,"pubDate":202,"description":203,"source":204},"Monte Rosa Therapeutics (NASDAQ:GLUE) Stock Rating Raised to \"Strong-Buy\" at HC Wainwright - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi4gFBVV95cUxPT2xHbEw4eENCaFJ0OURLcUhOakFFRDRvWG5LWFpqZmdra0hrVHExVXhmSWs4MUNwR2NSMkNWNnJYY20zNUJtTTd6X01oTndhOFZZM0x1QUlQMHAzNTJmeDhkRWpSYy1sNmltSV9rSzQ3T1JxSFpIRXFYQy1FeGJaV29wM0Q0azdfbm5Yek5QeXFhMlllVWdXcHRfMXlYTGZZRDdwX0plZ1ZVTUpiQktQWXcxcTVIakxHMEFtUmZaYVJHS19vSVhiOE05N3pWUGE5c09nWDJzR0NhVDUtY0c4WE5n?oc=5","Fri, 02 Oct 2026 11:38:58 GMT","Monte Rosa Therapeutics (NASDAQ:GLUE) Stock Rating Raised to \"Strong-Buy\" at HC Wainwright MarketBeat","MarketBeat",{"title":206,"link":207,"pubDate":208,"description":209,"source":210},"Monte Rosa Therapeutics Shares Surge Premarket - Monte Rosa Therapeutics (NASDAQ:GLUE) - Benzinga","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisAFBVV95cUxNWVMwNm9NS1hlekxtaVVOVTZ4WWs3a1RJQ2dlTjNUSVRKa21CX1RxU2hUakdYZjd1amltNUdhYmE5RWhEMUF0OWFZTXFHU1B4a3QxMnRXUU5RcjZacEN2amxLeVpZTzZldDZTTFhBWlZfdTVEdWtuemhvTTd4SjRPRF9wMDltSlhvU2xWUjBTdm92UWR6X0lvX1dDcVZVR0c4bnRySFdaNWtyY24wdTdiTA?oc=5","Thu, 01 Oct 2026 10:34:27 GMT","Monte Rosa Therapeutics Shares Surge Premarket - Monte Rosa Therapeutics (NASDAQ:GLUE) Benzinga","Benzinga",{"title":212,"link":213,"pubDate":214,"description":215,"source":216},"Safety and activity data will be presented Oct. 1 for people at elevated heart-disease risk after four weeks of treatment. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiugFBVV95cUxNQlRRWF9XNFFUb3Jkc01uVS1tWmdhX1ZMTkxyaC10d1ZWRVFDY0tGcjNkeFl0TEFENkpRdU5NSnlra05uMnJyeFNPSnVlRTlWSk12S3dUamN6eU5RUjJOUVZxT2pEOXBTRWpOTUg0RFVIVGRjWU5FM0h0WmFVZHRFWDl4dmQ4eDNSSlloZkM0ZXlNSDViNU5FMDd5Y0htb1JtNE4tU1pOVmpTOFRPWGFWMmpTT3ZldFFFVUE?oc=5","Wed, 30 Sep 2026 20:01:00 GMT","Safety and activity data will be presented Oct. 1 for people at elevated heart-disease risk after four weeks of treatment. Stock Titan","Stock Titan",{"title":218,"link":219,"pubDate":220,"description":221,"source":222},"Monte Rosa Therapeutics Stock In Focus After Phase 1 Data Win - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi7gFBVV95cUxQY0xDdnJoVHFFbkttTzY0eGVUUEo2cXl4WnhtQWlxaWllZFdBd0tSS2FrNkc4c0dZSjVVVUtKd2ItR3d3LTJOZkZhdkdweEN3Z3czZ0hkcnJSclktWVdPdmg4eERNa2w2RVVWZlo0bTl5RkhWTUstdWE5V0ZCWC1fa2k1b0xLbjN6QmFlYmRDMEY1SHdLMXlnTHdBX3I3aW1vTUdZSDVwbmM1N1RBR1VOZWx3anZ5QnMwZ1ZfMVBHS3AwYVdQUE9KcjBnSFBwbWw0XzREd3dmaUdFVkx0czM2YmlQeUNPT2FpQU5zRUJB0gHzAUFVX3lxTFBTYkREWUxNRmR5R1E2UkJzR2dqa0taUDAtYVUxOVlkazEyZFlIV2NpLUEyOWozbEMxZ3ZyQ1JUUWdlVVJVUS0yNmNZSlF5bDhCZEdSMUNNWFdmU1pCSERWOTg1NkVBWVlZd3BzMnRLNExrTVI2SHNMX0J4Vk1wUXQ5OGFXbmpvNm82d0o1YVZrSWhpUVU1UHBqLWRCQWc4a3kyQVYxaHoyb0RndzdTOHNJX1BfYkhEdFZmSnVXUzZoOXk3WGdFX1R4Wjkyc0pIZ212SWlCbFpQV1NNamYxUi1ab29Tem8zY2JiX29fTGNXV2JRdw?oc=5","Sat, 03 Oct 2026 06:32:47 GMT","Monte Rosa Therapeutics Stock In Focus After Phase 1 Data Win Simply Wall Street","Simply Wall Street",{"title":224,"link":225,"pubDate":226,"description":227,"source":228},"(GLUE) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiyAFBVV95cUxQWE1sekVFS004eWc3Y2hDbVAtMDhBUDlJMFZwWmZrQmwwcEpWWXhfNTBWWlQ0LVlvQkpxT2JGSkJZU296T2FGTDRsZG1aWUtZZmlWMVhPSDR2S3hud0dqcEVZRFdRTnpobFp4NjFJSmYwaFF4ZWtqaGhzZDVIbTl3Mnl6U3ZLZzAtaFgwZkQybXZzdGMyekM1dHd0bk15M3lxR3BjNXpiTVlOajlHNnpsajdnMTJlYk5VYTI0X0s5U0ZGNGNRN093RA?oc=5","Sun, 27 Sep 2026 06:52:02 GMT","(GLUE) Movement Within Algorithmic Entry Frameworks Stock Traders Daily","Stock Traders Daily",{"title":230,"link":231,"pubDate":232,"description":233,"source":234},"Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE) and Cullinan Management (CGEM) - The Globe and Mail","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimgJBVV95cUxQVi1GSkZqQTRERTFoYUozSGt0MUc2VkNTVFhHaEVVcmczV3dBN2VsTnNBWU1vczlCNm5NUERrb0VpaTF2emRPaWoyMXlpTlIxelF1ZThKTERpQ19icUFfMl9oWEtxN2ZGeTdYbW45UFRlc0hnUjI0V0VjWU8wUDBiODhyUHJjeWFKRzJMY2VsVnJhR0JrOUE5MExZaHZfVHktdnRvT0RvdWN1djlzekJHVDdxR3Z4eXhsX3gwOW1NdFZjbUNEYlF4QnV3WTQ0Z05aNFJ0ZU1ReWx5ZXp3aTUzZl9YT09qRjhfS3BkQzdwMS1kUElvdXNPWk0yV2V3VzQ0VEwwR25JcUhxeFV6eHBybWwyQ0t1dWllSlE?oc=5","Sat, 03 Oct 2026 14:16:00 GMT","Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE) and Cullinan Management (CGEM) The Globe and Mail","The Globe and Mail",{"title":236,"link":237,"pubDate":238,"description":239,"source":204},"Monte Rosa Therapeutics, Inc. $GLUE Shares Newly Acquired by Bank of America Corp DE - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi2gFBVV95cUxPaEQzaVpyb01lM2RwZzdvNkU3TnBDMXJGVk8tSEhmZW1KQWZUQWlaR0lQOE5RN1lIRUNKOUQ5cnFrb1ptZjc5RFpsaWFwUTNMNjN6bUx4VkEyMlFIVTB6Z1g4aGphWDRFM3MxVXBvUjlOM29pQ0RldTJNR0x4M0ppbXp1TjNCSEpqbEFmQTUwMGV6aDVmVjEtRGcybWZ6MnF0S2hXbHg3Vzg4eTBiMVVFUWVqazM2YzgwZTA2Mml6ZFBmZE50cmNxMjNJczhOSUJabWFEMVU0clA4UQ?oc=5","Mon, 28 Sep 2026 07:35:41 GMT","Monte Rosa Therapeutics, Inc. $GLUE Shares Newly Acquired by Bank of America Corp DE MarketBeat",{"title":241,"link":242,"pubDate":243,"description":244,"source":222},"What Monte Rosa Therapeutics (GLUE)'s Phase 2 Trial Start Means For Shareholders - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Tue, 22 Sep 2026 21:57:08 GMT","What Monte Rosa Therapeutics (GLUE)'s Phase 2 Trial Start Means For Shareholders Simply Wall Street",{"title":246,"link":247,"pubDate":248,"description":249,"source":210},"12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxPcDZGNHdSLVBnSHdMRVRKc2pxaVctNnNQVFlxRmZka3FIbnhwclV1OEJVay1pVkd2MkJVNTJBYjhQREpmcTZGRGd5MEdEUlhJVDFzMmpBRXlFVGhkeUY1ZkZHOEsyY1JMMmdUMkY0akdrUVA3VHk1VF9sR2cxLVJ4NlBZaHpIQWFocFZyRWhZMDloYjBUcmtlanptS0RLVzBtQ0F2b0FPb0ttNE5IZHhQQnIxWEZha2lQTGdyLU5hOA?oc=5","Wed, 30 Sep 2026 21:05:56 GMT","12 Health Care Stocks Moving In Wednesday's After-Market Session Benzinga",{"title":251,"link":252,"pubDate":253,"description":254,"source":216},"An experimental drug brought several heart-disease markers to levels seen in healthy volunteers - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxQVG8xQUI4R29BSllIR3lyR0o4Mk5mdlZHZFZfbFVLOWYzSFowd0FRVU0tTVBqOWhxR3JCRGRyM1hQeXU2SlRHcm9pa3VRQ0VaTkpFT2FqWXZ0d3Y4SkZXTU5tRUd4bTZUbmVlZThyR29XeDc5MUkxVl83MnQ2VTRudW45NG5WMGRwb3Zhekc5NkloVGppeXBWUzRQX0xxbk5iQ1NSOVBuSE5QX0dSaW5oUGZ6aE5EOFBuQUNKRmFB?oc=5","Thu, 01 Oct 2026 11:00:00 GMT","An experimental drug brought several heart-disease markers to levels seen in healthy volunteers Stock Titan",{"title":256,"link":257,"pubDate":258,"description":259,"source":180},"Newell Brands Inc. (NWL) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiUEFVX3lxTE1PcEN3UG1HVnR0YnFrWEFyMEhpSzR1VmlUTjhEX0d6d1FKRFV3ZHllVWQ4TXFhRE5yaUMxb2pXTktvOS1BYlNyR3laTTQwSFJ3?oc=5","Mon, 05 Oct 2026 05:43:57 GMT","Newell Brands Inc. (NWL) Stock Price, News, Quote & History Yahoo! Finance Canada",{"title":261,"link":262,"pubDate":263,"description":264,"source":204},"Monte Rosa Therapeutics (NASDAQ:GLUE) Shares Down 6% - What's Next? - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxQT1MxS1JITGpLbkJ2cE1tRDg1ZTBYNUQ4MWV6RmNDRkp4bjkweWV2RlBWTDBEaENRUHFoVUt6SG1FWGhOb2pyRG5KZ1gwOTEwcW4xcVczU09vZzA2R1RzY0MxQnl2NDcySDE1czU1NDJoTDM5YzZFRWVTeUlTLXlPS2NlNVY0UWVvdHFYb0R2RE1nZnV4Rkk0cnVjUG1scy1KQTllRkdhMFpvODhJTlh0bFZjYzVNMUNPdlZtRg?oc=5","Thu, 01 Oct 2026 17:48:10 GMT","Monte Rosa Therapeutics (NASDAQ:GLUE) Shares Down 6% - What's Next? MarketBeat",{"title":266,"link":267,"pubDate":268,"description":269,"source":204},"Brokers Set Expectations for GLUE Q3 Earnings - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirgFBVV95cUxNUy05RkJWS003QkRaaTFEQklrcjlTTFFmdnhKSXRqRXRxZGlkdzFPeE1FaGZMNUdnazFTZDliQ3pWZnVwQkFTX3BGOU91TVRjNU83Qkw2a2pjNlgtbGlZYmcxeG94bWdnR1BsRGlWM3FhT3FDLWFBU256RTlkYmlfTmNwUXVFaGEySVpOVTBkalpmR0FJSUNXZmpOZExCX1o5M2s5bGZPSnRySGFycVE?oc=5","Mon, 05 Oct 2026 05:22:17 GMT","Brokers Set Expectations for GLUE Q3 Earnings MarketBeat",{"title":271,"link":272,"pubDate":273,"description":274,"source":180},"Tyra Biosciences, Inc. (TYRA) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiUkFVX3lxTE5GeGl0M1o1MEpvSUYtNGhjVDZXR2paQ3dNbmhqdmI3T1ViV2tTdTFzSWZKRDBJV2twUmxWWjVhYXdvcTdWOGZjelQ1bmc0VnZyVVE?oc=5","Fri, 02 Oct 2026 06:27:04 GMT","Tyra Biosciences, Inc. (TYRA) Stock Price, News, Quote & History Yahoo! Finance Canada",{"title":276,"link":277,"pubDate":278,"description":279,"source":222},"Monte Rosa Therapeutics (GLUE) Following Phase 1 Data Faces A Big Fair Value Question - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Mon, 05 Oct 2026 10:17:31 GMT","Monte Rosa Therapeutics (GLUE) Following Phase 1 Data Faces A Big Fair Value Question Simply Wall Street",{"title":281,"link":282,"pubDate":283,"description":284,"source":285},"Cloudflare (NET) Shares Skyrocket, What You Need To Know - StockStory","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitgFBVV95cUxQWVJ3azJ2N0hVMUVZbGpLZnVQQktodEUwRW85U2tXcmVtRUlJNl9rWHVqelExdlBacmJTSGVpRmlsUTk4YjNMWlhxX21ZeVV4dlhlUjRBM0hCeUwzdU50ZXdfOEEwZzBJeFpBOWJ3eXA1Z0lBbWJndl9xSjlHanFtX0p6MWpjaFFFQUxWZkhOTUJnQzl0dFYzLWw3RTlZNXVUMDMzc1NaSFUxakxLek8zZkp2WXB4UQ?oc=5","Mon, 21 Sep 2026 17:44:36 GMT","Cloudflare (NET) Shares Skyrocket, What You Need To Know StockStory","StockStory"]